Edition:
United States

Biohit Oyj (BIOBV.HE)

BIOBV.HE on Helsinki Stock Exchange

3.93EUR
12:00pm EST
Change (% chg)

€0.00 (+0.00%)
Prev Close
€3.93
Open
€3.93
Day's High
€3.95
Day's Low
€3.90
Volume
25,386
Avg. Vol
14,167
52-wk High
€6.85
52-wk Low
€3.90

Chart for

About

Biohit Oyj is a Finland-based company engaged in the development, manufacture and marketing of diagnostic tests and analysis systems. The Company operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. It provides blood-sample... (more)
No analyst recommendations are available for .

Overall

Beta: 1.05
Market Cap(Mil.): €46.81
Shares Outstanding(Mil.): 11.91
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.83 15.71
EPS (TTM): -- -- --
ROI: -- 15.03 31.93
ROE: -- 16.54 16.16

BRIEF-Patent granted to Biohit Acetium® capsule in Japan

* AN IMPORTANT PATENT GRANTED TO BIOHIT ACETIUM® CAPSULE IN JAPAN

Sep 11 2017

BRIEF-Biohit H1 operating result swings to profit of EUR 7.4 mln

* H1 NET SALES EUR ‍4.1​ MILLION VERSUS EUR 3.8 MILLION YEAR AGO

Aug 17 2017

Earnings vs. Estimates

No consensus analysis data available.